Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,492) with videos related to
Page
of 150
Sort By:
Vaccine
|
February 1, 1997
In vivo protection against Androctonus australis hector scorpion toxin and venom by immunization with a synthetic analog of toxin II
I Zenouaki, R Kharrat, J M Sabatier, et al.
Clinical and Translational Allergy
|
March 14, 2012
Exhaled nitric oxide decreases after positive food-allergen challenge
Avigael H Benhamou, Alice Koehli, Isabelle Rochat, et al.
The American Journal of Pathology
|
January 12, 2002
CD40-CD40 ligand disruption does not prevent hyperoxia-induced injury
Constance Barazzone Argiroffo, Yves R Donati, Julien Boccard, et al.
Science (New York, N.Y.)
|
October 25, 2011
Antimicrobial peptides keep insect endosymbionts under control
Frédéric H Login, Séverine Balmand, Agnès Vallier, et al.
Optics Express
|
September 22, 2011
High rejection bandpass optical filters based on sub-wavelength metal patch arrays
J Le Perchec, R Espiau de Lamaestre, M Brun, et al.
Plos One
|
June 4, 2009
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells
Arun T Kamath, Anne-Françoise Rochat, Dennis Christensen, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
July 1, 1997
3D structure of kaliotoxin: is residue 34 a key for channel selectivity?
M Gairí, R Romi, I Fernández, et al.
Life Sciences
|
January 6, 2000
Cyclosporine A and purinergic receptors in rat kidney
G Halimi, J Sampol, O Clot-Faybesse, et al.
Health and Quality of Life Outcomes
|
February 19, 2008
Comparing a disease-specific and a generic health-related quality of life instrument in subjects with asthma from the general population
Milo A Puhan, Jean-Michel Gaspoz, Pierre-Olivier Bridevaux, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 23, 2006
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors
Michael P Hill, Paula Ravenscroft, Steven G McGuire, et al.
Page
of 150
Search research articles
Search
Showing results (1061-1070 of 1,492) with videos related to
Sort By:
Page
of 150
Vaccine
|
February 1, 1997
In vivo protection against Androctonus australis hector scorpion toxin and venom by immunization with a synthetic analog of toxin II
I Zenouaki, R Kharrat, J M Sabatier, et al.
Clinical and Translational Allergy
|
March 14, 2012
Exhaled nitric oxide decreases after positive food-allergen challenge
Avigael H Benhamou, Alice Koehli, Isabelle Rochat, et al.
The American Journal of Pathology
|
January 12, 2002
CD40-CD40 ligand disruption does not prevent hyperoxia-induced injury
Constance Barazzone Argiroffo, Yves R Donati, Julien Boccard, et al.
Science (New York, N.Y.)
|
October 25, 2011
Antimicrobial peptides keep insect endosymbionts under control
Frédéric H Login, Séverine Balmand, Agnès Vallier, et al.
Optics Express
|
September 22, 2011
High rejection bandpass optical filters based on sub-wavelength metal patch arrays
J Le Perchec, R Espiau de Lamaestre, M Brun, et al.
Plos One
|
June 4, 2009
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells
Arun T Kamath, Anne-Françoise Rochat, Dennis Christensen, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
July 1, 1997
3D structure of kaliotoxin: is residue 34 a key for channel selectivity?
M Gairí, R Romi, I Fernández, et al.
Life Sciences
|
January 6, 2000
Cyclosporine A and purinergic receptors in rat kidney
G Halimi, J Sampol, O Clot-Faybesse, et al.
Health and Quality of Life Outcomes
|
February 19, 2008
Comparing a disease-specific and a generic health-related quality of life instrument in subjects with asthma from the general population
Milo A Puhan, Jean-Michel Gaspoz, Pierre-Olivier Bridevaux, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 23, 2006
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors
Michael P Hill, Paula Ravenscroft, Steven G McGuire, et al.
Page
of 150